Fierce Biotech August 21, 2024
Medtech startups fared well in the second quarter with investment activity on track to surpass last year and venture capital exits are on the rise, according to PitchBook’s latest sector report.
It’s the latest sign that the medtech sector may be through its recent dry spell.
Medtech venture capital investment held steady in Q2 with $3.3 billion of deal value, down slightly from the $3.5 billion of activity in the first quarter, according to the report. The $3.3 billion in total deal value marks a 7% decline from Q1 but a 3.2% gain year over year.
This marks the second straight quarter of higher deal activity compared with the prior-year period. Through the first half of 2024, medtech VC...
Today's Sponsors
Today's Sponsor